Originally published as JCO Early Release 10.1200/JCO.2006.05.8321 on May 15 2006

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ganz, P. A. Articles by Lippman, S. M. Search for Related Content PubMed PubMed Citation Articles by Ganz, P. A. Articles by Lippman, S. M. Social Bookmarking                            What's this?

The Role of Prevention in Oncology Practice: Results From a 2004 Survey of American Society of Clinical Oncology Members

Patricia A. Ganz, Lorna Kwan, Mark R. Somerfield, David Alberts, Judy E. Garber, Kenneth Offit, Scott M. Lippman

From the University of California, Los Angeles (UCLA) Schools of Medicine and Public Health; Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA; American Society of Clinical Oncology, Alexandria, VA; University of Arizona Cancer Center, Tucson, AZ; Dana Farber Cancer Institute, Boston, MA; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Address reprint requests to Patricia A. Ganz, MD, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Center at UCLA, 650 Charles Young Drive South, Room A2-125 CHS, Los Angeles, CA 90095-6900; e-mail: pganz{at}ucla.edu

PURPOSE: In 2004, the American Society of Clinical Oncology (ASCO) Cancer Prevention Committee surveyed the members to describe involvement in clinical prevention activities.

METHODS: A previously administered survey, with updated items on genetics, chemoprevention, and survivorship, was mailed to a stratified random sample of 2,000 domestic members and a convenience sample of 3,144 international members.

RESULTS: A total of 49.7% of domestic members contacted and survey eligible responded (n = 851). Nonresponders were younger (50.5 v 51.7 years; P < .01); 465 international members responded. Overall, 35% had received formal instruction in cancer prevention and control, and most respondents expected increased use of prevention, screening/early detection, and risk reduction/genetic counseling in their practices in the next 5 years. Most reported caring for cancer survivors, including providing general medical care. They also either directly provide or refer patients for cancer prevention and control services (eg, cancer screening, tobacco and nutrition counseling, risk reduction, and chemoprevention). Multivariable modeling found fewer perceived barriers to inclusion of cancer prevention activities in clinical practice among those practicing in an academic setting, seeing a higher proportion of patients without a cancer diagnosis, having formal training in prevention and control, expecting an increase in prevention activities in the next 5 years, and providing community advice on prevention.

CONCLUSION: Barriers to the inclusion of cancer prevention and control activities in oncology clinical practice exist. Nevertheless, a substantial proportion of both domestic and international ASCO members report an interest in cancer prevention and control activities, with a desire for more specific educational programs in this emerging area of oncology practice.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. S. Kramer, K. L. Hagerty, S. Justman, M. R. Somerfield, P. C. Albertsen, W. J. Blot, H. Ballentine Carter, J. P. Costantino, J. I. Epstein, P. A. Godley, et al. Use of 5-{alpha}-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline J. Clin. Oncol., March 20, 2009; 27(9): 1502 - 1516. [Abstract] [Full Text] [PDF]

				R. T. Zon, E. Goss, V. G. Vogel, R. T. Chlebowski, I. Jatoi, M. E. Robson, D. S. Wollins, J. E. Garber, P. Brown, and B. S. Kramer American Society of Clinical Oncology Policy Statement: The Role of the Oncologist in Cancer Prevention and Risk Assessment J. Clin. Oncol., February 20, 2009; 27(6): 986 - 993. [Abstract] [Full Text] [PDF]

				ASCO Policy Statement Highlights Oncologist's Role in Providing Cancer Prevention Services J. Oncol. Pract, January 1, 2009; 5(1): 10 - 12. [Full Text] [PDF]

				W. Demark-Wahnefried, E. C. Clipp, I. M. Lipkus, D. Lobach, D. C. Snyder, R. Sloane, B. Peterson, J. M. Macri, C. L. Rock, C. M. McBride, et al. Main Outcomes of the FRESH START Trial: A Sequentially Tailored, Diet and Exercise Mailed Print Intervention Among Breast and Prostate Cancer Survivors J. Clin. Oncol., July 1, 2007; 25(19): 2709 - 2718. [Abstract] [Full Text] [PDF]

				R. Zon, E. Towle, M. Ndoping, J. Levinson, A. Colbert, and C. Williams Reimbursement for Preventive Counseling Services J. Oncol. Pract, September 1, 2006; 2(5): 214 - 218. [Full Text] [PDF]